FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria | FDA

FDA-Recognized Antimicrobial Susceptibility Test Interpretive Criteria | FDA

Notice of Updates – FDA Recognized Antimicrobial Susceptibility Test Interpretive Criteria

FDA Updates

For delafloxacin, FDA identified susceptibility test interpretive criteria for Staphylococcus lugdunensis for the indication Acute Bacterial Skin and Skin Structure Infections.

For additional information about the FDA susceptibility test interpretive criteria recognition please visit http://www.fda.gov/STIC.

** If you did not subscribe to the FDA Recognized Antimicrobial STIC Breakpoints subscription you may unsubscribe from this list by clicking on the "Manage Preferences or Unsubscribe from this List" link below.